Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 22, 2022 07:00 ET | Source: Tilray Brands, Inc.

Tilray Medical Receives Approval to Extend Market Authorization in Italy

LEAMINGTON, Ontario and CANTANHEDE, Portugal, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company...
September 16, 2022 08:00 ET | Source: BioNTech SE

Pfizer und BioNTech erhalten positive CHMP-Empfehlung für die Umwandlung der bedingten Marktzulassung von COMIRNATY® in eine vollständige Marktzulassung in der Europäischen Union

Die Empfehlung für eine Standardzulassung umfasst alle Indikationen und Formulierungen, die in der Europäischen Union zugelassen sind, einschließlich der bivalenten Impfstoffe COMIRNATY®...
September 16, 2022 08:00 ET | Source: BioNTech SE

Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union

Standard marketing authorization recommendation applies to all indications and formulations in the European Union, including COMIRNATY® Original/Omicron BA.4-5 and COMIRNATY® Original/Omicron BA.1...
April 04, 2019 12:31 ET | Source: NANOBIOTIX

NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCHÉ EUROPEEN D’UN RADIOENHANCER

NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCHÉ EUROPEEN D’UN RADIOENHANCER Hensify®(NBTXR3) a reçu une autorisation de mise sur le marché (Marquage CE) en Europe...
April 04, 2019 12:31 ET | Source: NANOBIOTIX

Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval

NANOBIOTIX ANNOUNCES FIRST EVER RADIOENHANCER TO RECEIVE EUROPEAN MARKET APPROVAL Hensify®(NBTXR3) received European market approval (CE mark) enabling commercialization in 27 European Union...